As noted previously, some of the evaluated health outcomes could be driven by BBS, obesity or both; the current analysis was not designed to delineate between what outcomes were specifically BBS related versus obesity related. Here, BBS2 is linked to obesity due to melanocortin 4 receptor deficiency.